ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ETNB 89bio Inc

9,22
0,36 (4,06%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
89bio Inc ETNB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,36 4,06% 9,22 06:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
9,19 8,90 9,35 9,22 8,86
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.3.202423:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..
01.3.202423:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202422:10EDGAR2Form 8-K - Current report
24.2.202402:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.2.202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202417:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202322:43EDGAR2Form 8-K - Current report
08.12.202312:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06.12.202322:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06.12.202322:02EDGAR2Form 8-K - Current report
04.12.202313:01EDGAR2Form 8-K - Current report
27.11.202314:01EDGAR2Form 8-K - Current report
14.11.202322:30EDGAR2Form 8-K - Current report
09.11.202321:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202302:41EDGAR2Form 8-K - Current report
21.9.202315:07DJN89bio Gets FDA Breakthrough Designation for Pegozafermin in..
12.9.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202322:27EDGAR2Form 8-K - Current report
09.8.202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:12EDGAR2Form 8-K - Current report
06.7.202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.7.202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock